Avtor/Urednik		Petrovič, Danijel
Naslov		Nicorandil - new agent for the treatment of coronary artery disease
Tip		članek
Vir		In: Pajer Z, Štiblar-Martinčič D, editors. International symposium on cardiovascular diseases. Proceedings of the 29th memorial meeting devoted to prof. dr. Janez Plečnik; 1998 Dec 3-5; Ljubljana. Ljubljana: Medical faculty, Institute of histology and embryology,
Leto izdaje		1998
Obseg		str. 107-10
Jezik		eng
Abstrakt		Nicorandil is the drug marketed for the long-term treatment of angina pectoris. Nicorandil combines the properties of an organic nitrate with those of potassium-channel activator, causing dilation of coronary arteries and arterioles, systemic resistance vessels and veins. The principal side effect is mild to moderate headache. The main indication for the use of nicorandil is slable angina pectoris, providing an alternative or addition to the conventional therapy.
Deskriptorji		CORONARY DISEASE NIACINAMIDE ANGINA PECTORIS